ARNA Historical PE Ratio image   This ARNA PE ratio history page last updated 5/11/2022
ARNA Historical PE Ratio Chart
Data adjusted for ARNA split history

PeriodPriceGAAPAnnualizedPE
Q4 2021
2/23/2022
93.99-2.54-10.16NA
Q3 2021
11/4/2021
63.00-3.21-12.84NA
Q2 2021
8/5/2021
62.10-2.40-9.60NA
Q1 2021
5/5/2021
64.30-1.98-7.92NA
Q4 2020
2/23/2021
76.56-2.10-8.40NA
Q3 2020
11/9/2020
87.42-1.69-6.76NA
Q2 2020
8/5/2020
64.43-1.61-6.44NA
Q1 2020
5/7/2020
49.85-2.00-8.00NA
Q4 2019
2/26/2020
46.79-1.76-7.04NA
Q3 2019
11/7/2019
48.23-1.46-5.84NA
Q2 2019
8/7/2019
60.91-1.24-4.96NA
Q1 2019
5/8/2019
49.5212.3449.361.0
Q4 2018
2/26/2019
50.37-0.82-3.28NA
Q3 2018
11/7/2018
38.67-0.70-2.80NA
Q2 2018
8/6/2018
37.85-0.65-2.60NA
Q1 2018
5/8/2018
42.02-0.78-3.12NA
Q4 2017
3/14/2018
36.03-0.36-1.44NA
Q3 2017
11/7/2017
27.90-0.55-2.20NA
Q2 2017
8/7/2017
23.36-0.77-3.08NA
Q1 2017
5/9/2017
12.90-9.00-36.00NA
Q4 2016
3/14/2017
14.2025.00100.000.1
Q3 2016
11/7/2016
14.70-5.00-20.00NA
Q2 2016
8/8/2016
16.80-9.00-36.00NA
Q1 2016
5/9/2016
15.80-9.00-36.00NA
Q4 2015
2/29/2016
14.90-11.00-44.00NA
Q3 2015
11/10/2015
19.00-11.00-44.00NA
Q2 2015
8/5/2015
40.30-11.00-44.00NA
Q1 2015
5/11/2015
41.50-10.00-40.00NA
Q4 2014
3/2/2015
42.80-15.00-60.00NA
Q3 2014
2/10/2015
44.90-5.00-20.00NA
Q2 2014
8/1/2014
44.603.0012.003.7
Q1 2014
5/12/2014
68.40-12.00-48.00NA
Q4 2013
2/27/2014
67.70-11.00-44.00NA
Q3 2013
11/7/2013
40.80-8.00-32.00NA
Q2 2013
8/1/2013
68.6018.0072.001.0
Q1 2013
5/2/2013
84.00-9.00-36.00NA
Q4 2012
3/4/2013
81.90-10.00-40.00NA
Q3 2012
11/6/2012
76.00-7.00-28.00NA
Q2 2012
8/9/2012
73.60-12.00-48.00NA
Q1 2012
5/1/2012
23.40-18.00-72.00NA
ARNA PE History Chart
PeriodPriceGAAPTTMPE
Q4 2021
2/23/2022
93.99-2.54-10.13NA
Q3 2021
11/4/2021
63.00-3.21-9.69NA
Q2 2021
8/5/2021
62.10-2.40-8.17NA
Q1 2021
5/5/2021
64.30-1.98-7.38NA
Q4 2020
2/23/2021
76.56-2.10-7.40NA
Q3 2020
11/9/2020
87.42-1.69-7.06NA
Q2 2020
8/5/2020
64.43-1.61-6.83NA
Q1 2020
5/7/2020
49.85-2.00-6.46NA
Q4 2019
2/26/2020
46.79-1.767.885.9
Q3 2019
11/7/2019
48.23-1.468.825.5
Q2 2019
8/7/2019
60.91-1.249.586.4
Q1 2019
5/8/2019
49.5212.3410.174.9
Q4 2018
2/26/2019
50.37-0.82-2.95NA
Q3 2018
11/7/2018
38.67-0.70-2.49NA
Q2 2018
8/6/2018
37.85-0.65-2.34NA
Q1 2018
5/8/2018
42.02-0.78-2.46NA
Q4 2017
3/14/2018
36.03-0.36-10.68NA
Q3 2017
11/7/2017
27.90-0.5514.681.9
Q2 2017
8/7/2017
23.36-0.7710.232.3
Q1 2017
5/9/2017
12.90-9.002.006.5
Q4 2016
3/14/2017
14.2025.002.007.1
Q3 2016
11/7/2016
14.70-5.00-34.00NA
Q2 2016
8/8/2016
16.80-9.00-40.00NA
Q1 2016
5/9/2016
15.80-9.00-42.00NA
Q4 2015
2/29/2016
14.90-11.00-43.00NA
Q3 2015
11/10/2015
19.00-11.00-47.00NA
Q2 2015
8/5/2015
40.30-11.00-41.00NA
Q1 2015
5/11/2015
41.50-10.00-27.00NA
Q4 2014
3/2/2015
42.80-15.00-29.00NA
Q3 2014
2/10/2015
44.90-5.00-25.00NA
Q2 2014
8/1/2014
44.603.00-28.00NA
Q1 2014
5/12/2014
68.40-12.00-13.00NA
Q4 2013
2/27/2014
67.70-11.00-10.00NA
Q3 2013
11/7/2013
40.80-8.00-9.00NA
Q2 2013
8/1/2013
68.6018.00-8.00NA
Q1 2013
5/2/2013
84.00-9.00-38.00NA
Q4 2012
3/4/2013
81.90-10.00-47.00NA
Q3 2012
11/6/2012
76.00-7.00NANA
Q2 2012
8/9/2012
73.60-12.00NANA
Q1 2012
5/1/2012
23.40-18.00NANA
Quotes delayed 20 minutes

Email EnvelopeFree ARNA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Arena Pharmaceuticals (ARNA) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

ARPO PE Ratio History
ARQT PE Ratio History
ARTL PE Ratio History
ARVN PE Ratio History
ARWR PE Ratio History
ASMB PE Ratio History
ASRT PE Ratio History
ATEC PE Ratio History
ATHA PE Ratio History
ATHX PE Ratio History
How should the ARNA historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Arena Pharmaceuticals. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this ARNA Historical PE Ratio page.

What is the average historical PE for ARNA based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The ARNA historical PE ratio using the annualized quarterly earnings method works out to 1.5.

What is the average historical PE for ARNA based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The ARNA historical PE ratio using the TTM earnings method works out to 5.1.

On this page we presented the ARNA Historical PE Ratio information for Arena Pharmaceuticals' stock. The average ARNA historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 1.5. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average ARNA historical PE based on this TTM earnings result method is 5.1. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this ARNA historical PE result, against the recent PE: when this page was posted on 3/11/2022, the most recent closing price for ARNA had been 99.99, and the most recent quarterly earnings result, annualized, was 49.36. Meanwhile, the most recent TTM earnings summed to 7.88. From these numbers, we calculate the recent ARNA PE on 3/11/2022 based on annualized quarterly EPS was 2.0. Based on ARNA's history, that recent PE is elevated relative to the historical average, with the recent PE 33.3% higher than the historical average PE across our data set for Arena Pharmaceuticals. Looking at the recent ARNA PE on 3/11/2022 based on TTM EPS, we calculate the ratio at 12.7. Based on ARNA's history, that recent PE is elevated relative to the historical average, with the recent PE 149.0% higher than the historical average PE across our Arena Pharmaceuticals data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on ARNA or any other given stock, valuation analysis for ARNA can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Arena Pharmaceuticals PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for ARNA. Thanks for visiting, and the next time you need to research ARNA Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Funds Holding CHI, PAYA Historical Stock Prices, AVTE Videos.

 

ARNA Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.